Heron Therapeutics, Inc.【HRTX】 業績推移・財務諸表

(単位:千ドル) 2Q11 3Q11 1Q12 2Q12 3Q12 4Q12 1Q13 2Q13 3Q13 4Q13 1Q14 2Q14 3Q14 4Q14 1Q15 2Q15 3Q15 4Q15 1Q16 2Q16 3Q16 4Q16 1Q17 2Q17 3Q17 4Q17 1Q18 2Q18 3Q18 4Q18 1Q19 2Q19 3Q19 4Q19 1Q20 2Q20 3Q20 4Q20 1Q21 2Q21 3Q21 1Q22 2Q22 3Q22 1Q23 2Q23 3Q23 1Q24 2Q24 3Q24 1Q25
売上高 - - - - - - - - - - - - - - - - - - - - - 1,279 3,632 8,510 8,572 10,053 11,567 17,277 19,786 28,844 31,602 36,659 42,600 35,083 25,400 22,700 20,000 20,605 20,000 22,400 23,200 23,500 27,630 26,557 29,615 31,762 31,434 34,670 36,024 32,810 38,903
売上成長率(%) - - - - - - - - - - - - - - - - - - - - - - - - -
売上原価 - - - - - - - - - - - - - - - - - - - - - 35 1,186 1,013 1,051 1,338 3,133 5,231 7,576 11,572 14,962 13,588 17,195 15,874 10,622 9,005 7,170 9,392 9,207 14,522 11,351 11,355 16,175 14,717 16,854 20,158 18,208 8,444 10,518 9,458 8,457
売上総利益 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - 13,226 26,226 25,506 23,352 30,446
売上総利益率(%) - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
研究開発費 1,282 2,929 3,329 3,067 - - 6,772 10,531 5,885 - 11,771 14,427 14,731 14,195 14,504 16,175 14,241 16,263 16,092 27,286 30,242 29,505 33,384 28,597 28,844 47,757 39,561 30,159 30,421 39,891 42,972 41,425 34,708 48,277 36,894 44,004 49,182 44,453 38,116 35,233 28,595 42,070 28,834 25,545 13,817 17,572 13,558 4,608 4,432 4,465 2,279
営業費用 1,791 4,089 4,769 4,380 - 8,628 12,752 15,209 12,664 13,832 17,322 18,791 18,953 - 20,360 23,014 22,491 - 33,312 43,066 47,734 - 52,931 50,565 49,886 - 63,557 56,130 61,566 - 96,302 88,438 77,477 - 78,134 78,417 78,349 - 72,132 82,912 74,938 86,380 77,128 68,439 62,678 74,165 38,155 31,024 31,951 27,810 27,292
営業利益 -1,540 -4,089 -4,769 -4,380 - - -12,752 -15,209 -12,664 - -17,322 -18,791 -18,953 - -20,360 -23,014 -22,491 - -33,312 -43,066 -47,734 - -49,299 -42,055 -41,314 - -51,990 -38,853 -41,780 - -64,700 -51,779 -34,853 -59,362 -52,734 -55,749 -58,384 -61,296 -52,114 -60,469 -51,708 -62,923 -49,498 -41,882 -33,063 -42,403 -24,929 -4,798 -6,445 -4,458 3,154
営業利益率 (%) - - - - - - - - - - - - - - - - - - - - - - - -
経常(税引前)利益 - - -4,830 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
純利益 -1,932 -4,202 -4,921 -4,569 -6,121 -7,737 -12,953 -15,413 -12,873 -14,044 -17,538 -19,011 -19,194 -20,624 -20,570 -23,107 -22,672 -31,242 -33,445 -43,226 -48,509 -47,963 -50,329 -42,799 -41,866 -62,490 -52,265 -38,670 -38,346 -49,559 -63,012 -50,222 -33,595 -57,920 -51,579 -55,190 -58,228 -62,281 -52,614 -61,015 -52,408 -63,888 -56,359 -41,908 -32,800 -42,059 -25,008 -3,160 -9,235 -4,848 2,635
純利益率(%) - - - - - - - - - - - - - - - - - - - - -
一株あたり利益 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -0.55 -0.38 -0.27 -0.35 -0.17 -0.02 -0.06 -0.03 0.02
希薄化後一株あたり利益 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -0.55 -0.38 -0.27 -0.35 -0.17 -0.02 -0.06 -0.03 0.01
EBITDA - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
EBITDAマージン(%) - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -